Randomized controlled phase II study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer.

被引：0
|
作者：
Nakamura, Seiichi
Tatebe, Shigeru
Shimizu, Tetsu
Yamane, Nariyuki
Nishidoi, Hideaki
Kurisu, Yasuro
Kanayama, Hirotomo
Ogawa, Haruaki
Tsujitani, Shunichi
Ikeguchi, Masahide
机构：
[1] Tottori Prefectural Cent Hosp, Tottori, Japan
[2] Tottori Univ, Yonago, Tottori, Japan
[3] Yonago Med Ctr, Yonago, Tottori, Japan
[4] Tottori Red Cross Hosp, Tottori, Japan
[5] Hamada Med Ctr, Hamada, Japan
[6] Matsue City Hosp, Matsue, Shimane, Japan
[7] Yasugi Municipal Hosp, Yasugi, Japan
[8] Kyushu Univ, Dept Surg & Sci, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    Seiji Ito
    World Journal of Surgery, 2011, 35 : 470 - 471
  • [32] A prospective, randomized, controlled, multicenter study of apatinib combined with S-1 plus docetaxel as adjuvant therapy for locally advanced gastric cancer.
    Shan, Zhili
    Guo, Feng
    Chen, Hong
    Li, Dapeng
    Mao, Zhongqi
    Zhou, Jun
    Wu, Yongyou
    Sheng, Xudong
    Hu, Lijun
    Su, Jiang
    Cheng, Xu
    Kong, Zhiyuan
    Qiu, Huizhu
    Shan, Li
    Wu, Jianzhong
    Qiang, Zhenghai
    Gu, Yulan
    Zhou, Xiaojun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    Ito, Seiji
    WORLD JOURNAL OF SURGERY, 2011, 35 (02) : 470 - 471
  • [34] Examination of the feasibility of adjuvant chemotherapy with S-1 for gastric cancer
    Kawasaki, H
    Shibata, S
    Sasaki, M
    Proceedings of the 6th International Gastric Cancer Congress, 2005, : 191 - 194
  • [35] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    John Spiliotis
    Odysseas Zoras
    World Journal of Surgery, 2011, 35 : 468 - 469
  • [36] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
    Takahari, Daisuke
    Hamaguchi, Tetsuya
    Yoshimura, Kenichi
    Katai, Hitoshi
    Ito, Seiji
    Fuse, Nozomu
    Kinoshita, Taira
    Yasui, Hirofumi
    Terashima, Masanori
    Gotoh, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [37] Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
    Sakuramoto, Shinichi
    Sasako, Mitsuru
    Yamaguchi, Toshiharu
    Kinoshita, Taira
    Fujii, Masashi
    Nashimoto, Atsushi
    Furukawa, Hiroshi
    Nakajima, Toshifusa
    Ohashi, Yasuo
    Imamura, Hiroshi
    Higashino, Masayuki
    Yamamura, Yoshitaka
    Kurita, Akira
    Arai, Kuniyoshi
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18): : 1810 - 1820
  • [38] Phase I/II study of docetaxel, CDDP and S-1 in unresectable advanced gastric cancer.
    Takayama, T
    Sato, Y
    Okamoto, T
    Sagawa, T
    Abe, T
    Ihara, H
    Nagashima, H
    Kato, J
    Niitsu, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 362S - 362S
  • [39] Adjuvant chemotherapy of S-1 versus S-1 plus metformin for resected pancreatic cancer: A multicenter and randomized phase II trial.
    Narita, Masato
    Furukawa, Masayuki
    Sakamoto, Ichiro
    Itoh, Yutaka
    Nakano, Hiroshi
    Naka, Takuji
    Sudo, Takeshi
    Yahara, Noboru
    Aoki, Hideki
    Oota, Kouji
    Matsumoto, Toshifumi
    Shimokawa, Mototsugu
    Hisano, Terumasa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [40] Multicenter phase II study of neoadjuvant chemotherapy consisted with S-1 and oxaliplatin followed by gastrectomy for locally advanced gastric cancer.
    Okita, Yoshihiro
    Satake, Hironaga
    Okuyama, Hiroyuki
    Kondo, Masato
    Miki, Akira
    Watanabe, Takanori
    Hatachi, Yukimasa
    Kotaka, Masahito
    Iwamoto, Shigeyoshi
    Kato, Takeshi
    Tsuji, Akihito
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345